title: [Modern approaches to the therapy of biliary system diseases].
abstract: The therapeutic efficacy of duspatalin was evaluated in 72 patients with chronic cholecystitis and dyskinesia of the biliary tract (BT). Supplementation of duspatalin to the combined therapy in the patients with chronic cholecystitis shown to exert a pronounced therapeutic effect. This caused positive changes in clinical symptoms and BT function and quality of life, diminished the lithogenic properties of bile.
authors.forename: A R
authors.initials: AR
authors.lastname: Galiullin
authors.forename: G A
authors.initials: GA
authors.lastname: Khakamova
authors.forename: V V
authors.initials: VV
authors.lastname: Uliamaeva
authors.forename: G A
authors.initials: GA
authors.lastname: Latypova
authors.forename: D A
authors.initials: DA
authors.lastname: Gur'ev
authors.forename: L V
authors.initials: LV
authors.lastname: Volevach
mesh_terms: D042101:Acalculous Cholecystitis / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D000293:Adolescent; D000328:Adult; D001294:Attitude to Health; D002908:Chronic Disease; D006801:Humans; D010276:Parasympatholytics / Q000008:administration & dosage / Q000627:therapeutic use*; D010627:Phenethylamines / Q000008:administration & dosage / Q000627:therapeutic use*; D011788:Quality of Life; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D010276:Parasympatholytics; D010627:Phenethylamines; C005096:mebeverine